Hydrix Ltd
Hydrix Limited is an Australia-based specialist product designing, engineering and medical device distribution company.
The business
Hydrix Limited is an Australia-based specialist product designing, engineering and medical device distribution company. The Company is engaged in the development of comprehensive products. Its segments include Hydrix Services, Hydrix Medical and Hydrix Ventures. Hydrix Services segment offers a comprehensive range of engineering, development and regulatory consulting services, including software, electronics, mechanical, industrial design and general product development services. Hydrix Medical distributes disruptive cardiovascular technologies that address unmet needs of patients and healthcare providers. Products include the Guardian real-time heart attack warning system from Avertix Medical, Implicity’s cloud-based artificial intelligence (AI)-driven remote cardiac patient monitoring and data management solution, and Echo IQ’s AI technology. Hydrix Services segment’s portfolio companies include Gyder Surgical Pty Ltd, Avertix Medical Inc., Memphasys Limited, and Cyban Pty Ltd.
Small Caps Research
No research on Hydrix Ltd yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise HYD based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
Hydrix Wins Key Counter-Drone Contract with NIOA Group
Hydrix wins $1-1.2m counter-drone contract with NIOA; ramp from May 2026, milestones to 2027, amid AREO capital raise and trading halt.
Hydrix secures $2.5m deal to collaborate on development of SynCardia’s total artificial heart technology
Hydrix secures a $2.5m deal with SynCardia to collaborate on Emperor total artificial heart tech, launching a multi-stage development program.
Hydrix welcomes first AngelMed Guardian device implant in the US
Product innovation company Hydrix (ASX: HYD) received a welcome operational boost yesterday after one of the devices it distributes was successfully implanted into a patient with a prior acute coronary syndrome. Hydrix’s partner and product manufacturer, Angel Medical Systems (AngelMed), told the market that a former ALERTS Study patient in the United States had received […]
Hydrix confirms four Asia-Pacific cardiac patients receive AngelMed Guardian heart attack alert implant
Cardiovascular technology promoter Hydrix (ASX: HYD) has confirmed its AngelMed Guardian implantable heart attack alerting device has been used for the first time in four separate surgical procedures at a Singapore hospital. The surgeries were performed over three days last week on patients chosen based on their previous medical history and perceived benefits they would […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.